论文部分内容阅读
目的:分析止咳平喘汤治疗小儿咳嗽变异性哮喘的临床疗效。方法:应用数字随机抽选的方法,从本中心2015年1月-2016年1月接收并用孟鲁司特与特布他林联合治疗的33例咳嗽变异性哮喘患儿作为常规组,选取同期接收并应用止咳平喘汤治疗的33例同疾病患儿作为观察组,比较两组患儿的临床疗效。结果:观察组患儿的临床治疗总有效率为96.96%,止咳起效的时间为(4.65±2.53)d,显著优于常规组的75.75%、(6.13±2.23)d,组间比较,差异具有统计学意义(P<0.05)。结论:在西药的基础上应用止咳平喘汤治疗小儿咳嗽变异性哮喘,患儿止咳的时间较快,且临床治疗有效率较高。
Objective: To analyze the curative effect of Zhike Pingchuan Decoction in treating children with cough variant asthma. Methods: A total of 33 children with cough variant asthma received by our center from January 2015 to January 2016 and treated with montelukast and terbutaline were enrolled in this study. 33 patients with the same disease receiving and applying Zhike Pingchuan Decoction were selected as the observation group, and the clinical efficacy of the two groups was compared. Results: The total effective rate of clinical treatment in the observation group was 96.96%, the onset time of cough was (4.65 ± 2.53) d, which was significantly better than that in the conventional group (75.75%, 6.13 ± 2.23) d Statistically significant (P <0.05). Conclusion: Based on western medicine, Zhike Pingchuan Decoction is effective in treating cough variant asthma in children with cough fast, and the clinical treatment is effective.